Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure
- First Posted Date
- 2015-05-18
- Last Posted Date
- 2024-07-26
- Lead Sponsor
- Institut de Recherches Internationales Servier
- Target Recruit Count
- 19102
- Registration Number
- NCT02446990
- Locations
- 🇮🇹
Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy
🇬🇧Royal Brompton Hospital, London, United Kingdom
Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study
- First Posted Date
- 2015-05-12
- Last Posted Date
- 2020-01-03
- Lead Sponsor
- Institut de Recherches Internationales Servier
- Target Recruit Count
- 6505
- Registration Number
- NCT02441218
- Locations
- 🇸🇪
Göteborg University, Göteborg, Sweden
🇫🇷Hôpital Pitié-Salpétrière, Paris, France
Long-term Safety of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis (EYEGUARD-X)
- First Posted Date
- 2015-03-03
- Last Posted Date
- 2020-01-03
- Lead Sponsor
- Institut de Recherches Internationales Servier
- Target Recruit Count
- 71
- Registration Number
- NCT02375685
- Locations
- 🇦🇹
Medical Competence, Wien, Austria
🇫🇷CHU-Hôtel Dieu, Nantes, France
🇦🇺Lions Eye Institute, Nedlands, Australia
Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
- Conditions
- Interventions
- First Posted Date
- 2014-02-28
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Institut de Recherches Internationales Servier
- Target Recruit Count
- 174
- Registration Number
- NCT02073994
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
- Conditions
- Interventions
- First Posted Date
- 2014-02-28
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Institut de Recherches Internationales Servier
- Target Recruit Count
- 291
- Registration Number
- NCT02074839
- Locations
- 🇺🇸
John Hopkins Cancer Center, Baltimore, Maryland, United States
🇺🇸UT Southwestern Medical Center, Dallas, Texas, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer
- First Posted Date
- 2014-02-04
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Institut de Recherches Internationales Servier
- Target Recruit Count
- 76
- Registration Number
- NCT02053636
- Locations
- 🇫🇷
Institut Claudius Regaud Dpt d'Oncologie Médicale, Toulouse, France
🇫🇷Institut Gustave Roussy Dépt d'oncologie - Cancer du sein, Villejuif, France
🇧🇪Institut Jules Bordet, Brussels, Belgium
Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD™-B)
- First Posted Date
- 2013-10-18
- Last Posted Date
- 2020-01-03
- Lead Sponsor
- Institut de Recherches Internationales Servier
- Target Recruit Count
- 84
- Registration Number
- NCT01965145
- Locations
- 🇰🇷
Yonsei University Severance Hospital, Seoul, Korea, Republic of
🇬🇧St Thomas' Hospital, London, United Kingdom
Study of Oral Lucitanib (E-3810), a Dual VEGFR-FGFR Tyrosine Kinase Inhibitor, in Patients With Solid Tumors
- First Posted Date
- 2011-01-26
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Institut de Recherches Internationales Servier
- Target Recruit Count
- 134
- Registration Number
- NCT01283945
- Locations
- 🇫🇷
Hopital Louis Pradel, Lyon, France
🇫🇷Institute Gustave Roussy, Villejuif, Paris, France
🇮🇹European Institute of Oncology, Milano, Italy
Efficacy of Agomelatine in Patients With Obsessive-Compulsive Disorder
- Conditions
- Interventions
- First Posted Date
- 2010-04-22
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Institut de Recherches Internationales Servier
- Target Recruit Count
- 74
- Registration Number
- NCT01108393
- Locations
- 🇮🇱
Department of Psychiatry Chaim Sheba Medical Center, Tel Hashomer, Israel
S90652 in Paediatric Hypertension
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2018-04-12
- Lead Sponsor
- Institut de Recherches Internationales Servier
- Target Recruit Count
- 50
- Registration Number
- NCT00202592
- Locations
- 🇫🇷
Hôpital Necker Enfants Malades, Paris, France